From: Macronutrients quality indices and risk of metabolic syndrome and its components in Iranian adults
 | Carbohydrate quality index and its components | ||||||
---|---|---|---|---|---|---|---|
Dietary indices | Q1 | Q2 | Q3 | Q4 | P-trend | Per 1 SD | P-value |
Carbohydrate quality index | Â | Â | Â | Â | Â | Â | Â |
Median score | 10.0 | 12.0 | 14.0 | 16.0 | Â | Â | Â |
Follow up period | 6.1 | 6.2 | 6.9 | 6.8 | Â | Â | Â |
Model 1* | 1.00 (Ref) | 0.97 (0.82–1.16) | 0.84 (0.67–1.05) | 0.87 (0.72–1.06) | 0.100 | 0.93 (0.87–1.00) | 0.065 |
Model 2†| 1.00 (Ref) | 0.98 (0.82–1.17) | 0.81 (0.64–1.01) | 0.83 (0.69–1.00) | 0.025 | 0.92 (0.85–0.98) | 0.023 |
Glycemic index (per 1000Kcal) | Â | Â | Â | Â | Â | Â | Â |
Median score | 18.0 | 23.6 | 29.9 | 41.1 | Â | Â | Â |
Follow up period | 6.5 | 6.8 | 6.8 | 6.9 | Â | Â | Â |
Model 1* | 1.00 (Ref) | 1.09 (0.8–1.38) | 1.09 (0.82–1.45) | 0.98 (0.68–1.42) | 0.571 | 1.00 (0.87–1.15) | 0.926 |
Model 2†| 1.00 (Ref) | 1.12 (0.88–1.41) | 1.13 (0.84–1.51) | 1.11 (0.76–1.61) | 0.871 | 1.01 (0.89–1.16) | 0.792 |
Model 3‡ | 1.00 (Ref) | 1.02 (0.80–1.31) | 1.01 (0.73–1.36) | 0.92 (0.61–1.38) | 0.493 | 0.94 (0.81–1.10) | 0.480 |
Fiber intake(g/1000Kcal) | Â | Â | Â | Â | Â | Â | Â |
Median score | 12.5 | 16.6 | 20.2 | 26.7 | Â | Â | Â |
Follow up period | 6.3 | 7.0 | 6.4 | 7.0 | Â | Â | Â |
Model 1* | 1.00 (Ref) | 0.91 (0.75–1.11) | 0.92 (0.76–1.12) | 0.91 (0.75–1.10) | 0.309 | 0.89 (0.75–1.06) | 0.209 |
Model 2†| 1.00 (Ref) | 0.90 (0.74–1.09) | 1.02 (0.84–1.24) | 0.90 (0.74 − 1.09) | 0.481 | 0.90 (0.76–1.07) | 0.262 |
Model 3‡ | 1.00 (Ref) | 0.93 (0.76–1.13) | 1.05 (0.86–1.29) | 0.91 (0.75–1.11) | 0.996 | 0.91 (0.77–1.08) | 0.304 |
Whole grain/total grains | Â | Â | Â | Â | Â | Â | Â |
Median score | 0.03 | 0.08 | 0.15 | 0.26 | Â | Â | Â |
Follow up period | 6.6 | 6.4 | 6.8 | 6.7 | Â | Â | Â |
Model 1* | 1.00 (Ref) | 0.99 (0.81–1.20) | 0.93 (0.77–1.13) | 0.85 (0.69 − 1.04) | 0.090 | 0.95 (0.88–1.02) | 0.181 |
Model 2†| 1.00 (Ref) | 0.94 (0.78–1.14) | 0.92 (0.76 − 1.12) | 0.77 (0.63 − 0.95) | 0.016 | 0.94 (0.85–0.99) | 0.036 |
Model 3‡ | 1.00 (Ref) | 0.92 (0.76–1.12) | 0.89 (0.73–1.09) | 0.75 (0.60–0.94) | 0.012 | 0.91 (0.84–0.99) | 0.033 |
SCHO/TCHO | Â | Â | Â | Â | Â | Â | Â |
Median score | 0.31 | 0.40 | 0.50 | 0.67 | Â | Â | Â |
Follow up period | 6.6 | 6.4 | 7.1 | 6.2 | Â | Â | Â |
Model 1* | 1.00 (Ref) | 1.25 (0.93–1.68) | 1.11 (0.74–1.66) | 1.19 (0.69–2.05) | 0.851 | 1.01 (0.83–1.23) | 0.858 |
Model 2†| 1.00 (Ref) | 1.20 (0.89–1.61) | 0.99 (0.66–1.49) | 1.03 (0.60–1.79) | 0.516 | 0.96 (0.79–1.16) | 0.697 |
Model 3‡ | 1.00 (Ref) | 1.27 (0.90–1.63) | 1.02 (0.68–1.53) | 1.09 (0.63–1.88) | 0.642 | 0.98 (0.81–1.20) | 0.989 |